RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 113 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 307 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 307 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -33.3% | 307 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | -40.0% | 307 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | +25.0% | 307 | +72.5% | 0.00% | – |
| Q2 2021 | $4,000 | -20.0% | 178 | 0.0% | 0.00% | – |
| Q1 2021 | $5,000 | +400.0% | 178 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | -50.0% | 178 | -60.4% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 450 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 450 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | -50.0% | 450 | 0.0% | 0.00% | – |
| Q4 2019 | $4,000 | 0.0% | 450 | -10.5% | 0.00% | – |
| Q3 2019 | $4,000 | -50.0% | 503 | 0.0% | 0.00% | – |
| Q2 2019 | $8,000 | -11.1% | 503 | 0.0% | 0.00% | – |
| Q1 2019 | $9,000 | -10.0% | 503 | -21.0% | 0.00% | – |
| Q4 2018 | $10,000 | – | 637 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |